The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Antidepressants Market Expected To Change Between 2026 And 2030?
The antidepressants market has experienced consistent growth in recent years. This market is projected to expand from $17.9 billion in 2025 to $18.36 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.6%. Historically, this growth has been driven by factors such as the increasing occurrence of depression, heightened recognition of mental health issues, the introduction of SSRI medications, the enlargement of healthcare facilities, and intensified research and development efforts in psychopharmacology.
The antidepressants market is anticipated to experience steady expansion over the next few years, with its valuation projected to reach $20.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 2.8%. This growth during the forecast period is propelled by advancements in precision medicine, the integration of AI in mental health diagnostics, increasing adoption of digital therapeutics, the expansion of telemedicine services, and a rising demand for antidepressants among pediatric and geriatric demographics. Prominent trends for the upcoming period include personalized antidepressant therapy, the prevalence of telepsychiatry and remote mental health services, the use of mobile health applications for mood monitoring, an increase in awareness regarding mental health disorders, and a rise in geriatric and pediatric depression treatment.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2881&type=smp
What Underlying Factors Are Accelerating The Growth Of The Antidepressants Market?
The increasing prevalence of mental illness is projected to drive demand within the antidepressants market in the future. A mental illness is defined as a condition that impacts how a person thinks, feels, behaves, or believes. These conditions often arise from distress or challenges in functioning across social, occupational, or family contexts. Antidepressants are medications employed to address various mental health issues, including depression, anxiety, and mood disorders, by raising the levels of particular brain chemicals responsible for regulating mood and emotions. For instance, in October 2025, the Care Quality Commission (CQC), a UK-based independent regulator of health and adult social care in England, noted that in 2024/25, new referrals to secondary mental health services averaged 453,930 per month, indicating a 15% increase compared to 2022/23. Consequently, the rising incidence of mental illness will fuel the antidepressants market.
How Is The Antidepressants Market Structured Across Different Segments?
The antidepressants market covered in this report is segmented –
1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder
Subsegments:
1) By Selective Serotonin Reuptake Inhibitor (SSRI): Fluoxetine, Sertraline, Escitalopram, Paroxetine, Citalopram
2) By Serotonin-norepinephrine Reuptake Inhibitor (SNRI): Venlafaxine, Duloxetine, Desvenlafaxine
3) By Tricyclic Antidepressant (TCA): Amitriptyline, Nortriptyline, Imipramine, Doxepin
4) By Monoamine Oxidase Inhibitor (MAOI): Phenelzine, Tranylcypromine, Isocarboxazid
Which Trends Are Shaping The Future Of The Antidepressants Market?
Leading companies in the antidepressant market are increasingly focusing on introducing novel drugs like ZURZUVAE (zuranolone) for treating postpartum depression (PPD) to maximize their market revenue. Postpartum depression (PPD) is a form of depression that can manifest after childbirth, constituting a serious mental health condition capable of affecting both new mothers and fathers. For example, in August 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics, Inc., a US-based biopharmaceutical company, unveiled ZURZUVAE (zuranolone), a 50 mg oral treatment for postpartum depression (PPD) in women. This introduction signifies a major advancement, addressing PPD which is often underdiagnosed and undertreated. ZURZUVAE (zuranolone) is an oral therapy primarily intended for postpartum depression (PPD) and stands as the first and only FDA-approved medication specifically engineered for this condition.
Which Major Players Dominate The Antidepressants Market?
Major companies operating in the antidepressants market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, H. Lundbeck AS, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Mylan N.V, Sun Pharmaceuticals Pvt. Ltd., Servier Laboratories, Sumitomo Dainippon Pharma Co., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Allergan plc, Alkermes plc, Egis Pharmaceuticals plc, Forest Laboratories Inc.
Read the full antidepressants market report here:
https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report
Which Region Is Projected To Dominate The Antidepressants Market During The Forecast Period?
North America was the largest region in the antidepressants market in 2025. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antidepressants Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2881&type=smp
Browse Through More Reports Similar to the Global Antidepressants Market 2026, By The Business Research Company
Antidepressant Market Report 2026
https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report
Antipsychotic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report
Anticholinergic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model